Skip to main content
logo
Sanofi (LON:0O59)
London flag London · Delayed Price · Currency is GBP · Price in EUR
76.49
+0.69 (0.91%)
At close: Mar 12, 2026

Revenue

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Dupixent Revenue
15.71B13.07B
Dupixent Revenue Growth
20.21%22.00%
Pharma Revenue
35.69B32.78B
Pharma Revenue Growth
8.87%-
Total Vaccine Revenue
7.94B8.30B
Total Vaccine Revenue Growth
-4.36%11.03%
BioPharma Revenue
43.63B41.08B
BioPharma Revenue Growth
6.19%8.63%
Revenue (Other)
-12.62B-9.87B
Revenue (Total)
46.72B44.29B
Revenue (Total) Growth
5.49%6.41%

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
22.18B19.99B
United States Revenue Growth
10.96%7.96%
Europe Revenue
9.17B9.03B
Europe Revenue Growth
1.57%-13.13%
Rest of World Revenue
12.28B12.07B
Rest of World Revenue Growth
1.76%-14.81%
Revenue (Other)
3.09B3.21B
Revenue (Total)
46.72B44.29B
Revenue (Total) Growth
5.49%6.41%

EBIT

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Biopharma Operating Income
12.12B11.29B
Biopharma Operating Income Growth
7.43%1.17%
Other (Post-2022 Reporting) Operating Income
26.00M58.00M
Other (Post-2022 Reporting) Operating Income Growth
-55.17%152.17%
Operating Income (Total)
6.34B7.25B
Operating Income (Total) Growth
-12.52%4.20%
Updated Dec 31, 2025. Data Source: Fiscal.ai.